PARP1 and T-cell non-Hodgkin lymphoma: Again, the potential clinical relevance of these observations is shown by the similarly increased phosphorylation of histone 2AX and cleavage of PARP1, caspase 3 and caspase 9 in the T-cell lymphoma patient cell sample exposed to romidepsin (Figure 4b).